Paroxysmal Nocturnal Hemoglobinuria (PNH) by FLAER (High Sensitivity)
Expected Turnaround Time
Stated turn-around-times (TATs) are for clinical use only and subject to change based on biopharma protocol requirements. Final TATs will be specified in the biopharma study contract.
Clinical Information
Requisition Forms
Specimen Requirements
Specimen Requirements
Whole Blood: 4 mL (minimum of 0.5 mL with 107 cells), NaHep preferred (EDTA accepted)
Specimen Stability
Specimen stable for 48 hours at 4°C.
Storage Requirements
2°C to 8°C
Shipping Conditions
Shipping Recommendations
REFRIGERATED, Use a refrigerated (NOT FROZEN) gel pack in the shipment to protect from extreme temperatures. Separate gel pack from specimen
Specimen Rejection Criteria
Specimens stored at incorrect temperature; Non-viable specimens; Specimens in inappropriate anticoagulant; Too few cells; Hemolysis; Specimen clotted
Test Details
Synonyms
PNH Screen, high sensitivity analysis for PNH, CD59, FLAER, GPI deficiency
Keywords
Test Method
Methodology Category
Regulatory Status
Associations
Coombs negative hemolytic anemia, myelodyspastic syndromes with unilineage dysplasia and unexplained hemoglobinuria, aplastic anemia, cytopenia or thrombosis; Soliris® (Eculizumab)
Get Expert Guidance on Paroxysmal Nocturnal Hemoglobinuria (PNH) by FLAER (High Sensitivity)
Our laboratory specialists can help you understand test requirements, methodology, and interpretation.
Connect with an Expert Today